De Nouvelles Données pour Lacutamab Issues de l'Essai TELLOMAK Seront Partagées Lors d'Une Présentation Orale au 16ème Congrès International du Lymphome Malin
June 09, 2021 06:00 ET
|
INNATE PHARMA
Marseille, France , 09 juin 2021 (GLOBE NEWSWIRE) -- Innate Pharma SA (Euronext Paris : IPH – ISIN : FR0010331421 ; Nasdaq : IPHA) (« Innate » ou la « Société ») annonce aujourd’hui que les données...
New Lacutamab Data from TELLOMAK Trial to be Showcased in Oral Presentation at Upcoming 16th International Conference on Malignant Lymphoma
June 09, 2021 06:00 ET
|
INNATE PHARMA
Marseille, France, June 09, 2021 (GLOBE NEWSWIRE) -- Innate Pharma SA (Euronext Paris: IPH – ISIN: FR0010331421; Nasdaq: IPHA) (“Innate” or the “Company”) today announced that preliminary mycosis...
New Lacutamab Data From Tellomak Trial to be Showcased in Oral Presentation at Upcoming 16th International Conference on Malignant Lymphoma
June 09, 2021 06:00 ET
|
INNATE PHARMA
MARSEILLE, France, June 09, 2021 (GLOBE NEWSWIRE) -- Innate Pharma SA (Euronext Paris: IPH – ISIN: FR0010331421; Nasdaq: IPHA) (“Innate” or the “Company”) today announced that preliminary mycosis...
Résultats de l’Assemblée Générale d'Innate Pharma
May 28, 2021 16:01 ET
|
INNATE PHARMA
Marseille, France, 28 mai 2021 (GLOBE NEWSWIRE) -- Innate Pharma SA (Euronext Paris : IPH – ISIN : FR0010331421 ; Nasdaq : IPHA) (« Innate » ou la « Société ») annonce les résultats du vote des...
Outcome of Innate Pharma’s Annual General Meeting
May 28, 2021 16:01 ET
|
INNATE PHARMA
Marseille, France, May 28, 2021 (GLOBE NEWSWIRE) -- Innate Pharma SA (Euronext Paris: IPH – ISIN: FR0010331421; Nasdaq: IPHA) (“Innate” or the “Company”) announced the voting results of its...
Outcome of Innate Pharma’s Annual General Meeting
May 28, 2021 16:01 ET
|
INNATE PHARMA
MARSEILLE, France, May 28, 2021 (GLOBE NEWSWIRE) -- Innate Pharma SA (Euronext Paris: IPH – ISIN: FR0010331421; Nasdaq: IPHA) (“Innate” or the “Company”) announced the voting results of its...
Number of Shares and Voting Rights of Innate Pharma as of May 1, 2021
May 25, 2021 01:00 ET
|
INNATE PHARMA
MARSEILLE, France, May 25, 2021 (GLOBE NEWSWIRE) -- Pursuant to the article L. 233-8 II of the French “Code de Commerce” and the article 223-16 of the French stock-market authorities (Autorité des...
Nouveau Nombre D'Actions et de Droits de Vote d'Innate Pharma au 1er Mai 2021
May 25, 2021 01:00 ET
|
INNATE PHARMA
Marseille, France, 25 mai 2021 (GLOBE NEWSWIRE) -- Conformément aux articles L. 233-8 II du Code de Commerce et 223-16 du règlement général de l’Autorité des marchés financiers (l’« AMF »), Innate...
Number of Shares and Voting Rights of Innate Pharma as of May 1, 2021
May 25, 2021 01:00 ET
|
INNATE PHARMA
Marseille, France, May 25, 2021 (GLOBE NEWSWIRE) -- Pursuant to the article L. 233-8 II of the French “Code de Commerce” and the article 223-16 of the French stock-market authorities (Autorité des...
Innate Pharma Virtual 2021 Annual General Meeting
May 12, 2021 01:00 ET
|
INNATE PHARMA
MARSEILLE, France, May 12, 2021 (GLOBE NEWSWIRE) -- Innate Pharma SA (Euronext Paris: IPH – ISIN: FR0010331421; Nasdaq: IPHA) (“Innate” or the “Company”) has published the convening notice to the...